FDA Announces Plan to Reform Drug Approval, Hire Outside Experts To Handel Some Reviews
In Brief: Walter Lawrence, Reginald Ho Lead ACS; Henderson To Leave Dana-Farber for UCSF
NCI To Fund More Than 1,000 Competing Grants Under FY 1992 Budget
FDA Panel urges Breast Implant Studies, Says Devices Should Remain Available
DCE Advisors Okay Study Of Cancer Risk in Breast Augmentation
DCE Technical Support Contracts Recompetition Approved in Concept
Trending Stories
- Lou Weiner: Poetry and art help us imagine my mother’s world as a hidden child of the Holocaust
- GOP-led Congress rejects Trump’s plans to gut medical research
Senate bill gives NIH a $400 million raise - Vinay Prasad falls from grace at FDA upon flunking Trump political purity test
MAHA leaders agree on one point: COVID was mishandled. Is that enough to run science-based agencies? - ACOG says it will no longer accept federal funding
- Andrea Werblin Reid’s unflinching poetry documents the realities of cancer care, clinical trials, and loss
Her collection, “To See Yourself As You Vanish,” will be published three years after her death - U.S. News & World Report expands evaluation of outcomes in cancer subspecialties